Genhouse Bio Entered into Collaborative Agreement with AI Drug Development Company XtalPi


On June 10th 2021, Genhouse Bio, a biotech company focusing on development of next-generation anti-cancer therapeutics, announced today that the company will collaborate with leading AI Drug Development Company Xtalpi on the discovery and development of novel small molecule candidates targeting solid tumors.


The collaboration between Genhouse and XtalPi is the strong alliance between advanced translational medicine technology platform and cutting-edge AIDD technology platform. Based on its integrated technology platforms, Genhouse has accumulated plentiful multiple-year experience in target validation and MoA research and is capable of in-depth basic structure biology studies.


Proprietary artificial intelligence-empowered innovative drug discovery platform from XtalPi, in combination with most advanced tools in computational chemistry in high accuracy and high through-put medicinal chemistry assays, make molecule design, performance assessment and chemical synthesis completed as workflow. Additionally, candidates with novel backbone designs will be further optimized with regard to high performance in activity, selectivity and clinical safety via continuous feedback and iteration. Meanwhile, intellectual patent of molecule is secured.


The collaboration between Genhouse and XtalPi will focus on novel targets to develop next-generation first-in-class anti-cancer therapeutics for the global market.


Original innovation in China is driven by clinical unmet medical needs. The common goal of drug development biotechnology companies is to provide high-quality therapeutics with better efficacy and safety to improve patient survival and life quality. Genhouse and XtalPi hope to provide broader and better treatment options for global cancer patients through continuous innovation and combination of technology platforms.


“The collaboration between Genhouse and leading AIDD company XtalPi is undoubtfully another exciting news for us,“ said Kuifeng Wang, Founder and CEO of Genhouse, “Genhouse focuses on targeting those ‘undruggable’ targets and original innovation. In order to fulfill clinical unmet medical needs of global cancer patients, we keep watching on and are willing to embrace new technologies. We believe this collaboration is a strong alliance between translational medicine technology platforms and AIDD technology platforms. We will keep exploit our advantages in structural biology and translational medicine research to bring broader and better treatment options to global cancer patients.”


“Discovery and development of anti-cancer therapeutics have enormous social and economic value for public health, but at the same time it posts great technical challenges for the biomedical industry. New technologies such as AI present new opportunities to significantly improve the efficiency and success rate of new drug development, accelerating the process of moving innovative drug candidates from lab to market. We are glad to collaborate with Genhouse, who focuses on the development of next-generation anti-cancer therapeutics. We will combine the technical advantages of both and push more and more high-quality innovative drug candidates to the market together.”

Privacy Statement

Genhouse Bio (Suzhou) Ltd. (“Genhouse” or “We”) respects the privacy of visitors (“Users”) to our website (“Site”), so we have developed this website privacy statement (“Privacy Statement”). This Privacy Statement indicates what information we collect about you and how that information is used. We may update the content of the Privacy Statement and suggest reading it regularly when you visit our Site.

Personal Information Collected by Genhouse

When you visit the Site, usually we will not collect any personal information from you. We might track your DNS and analyze the data to obtain understanding on visit trends. However, your identity will always remain anonymous, unless you specifically and knowingly provide it to us. When you provide such information, we will collect your personal information, such as when you contact us through the phone number or email address posted on the Site. But no matter when and how we collect your personal information, we will always provide link to this Privacy Statement. By willingly providing your personal information to us, you make the consent that we could use the information collected according to this Privacy Statement and admit that the information will be transferred from your locale to our office or server.

Information Disclosures and Sharing

Except as provided below, we will not share or sell your Personal Information with third parties unless otherwise stated by this Privacy Statement.

We might share your information according to this Privacy Statement, with Related Party who have consented to follow this Privacy Statement. Your personal information might also be transferred to other Related Party who represents us for purpose stated when we collect those information or other purposes permitted by law, such as Site evaluation, data management or technical support.

We might sell or buy business or assets during our operation. If Genhouse is acquired, merged, reorganized or dissolved or other alike situations happened, personal information might be part of the assets transferred. We may share personal information to respond to duly authorized subpoenas or other lawful information requests of governmental authorities, including to meet national security or law enforcement requirements, to provide Internet security, or where required by law.


We might put a digital tag (more precisely “cookies”) on your hard disk driver for the server to recognize your computer and track usage information. Cookies will not reveal your personal information and you could always stay anonymous to us. The information we collected from Cookies will only be used for internal purpose and improve the service we provided to you through the Site. Users of our Site always have the option of disabling cookies via their browser preferences. If under any circumstances we collected your personal information, we will always inform you with your planned usage, contact and any Third Party that might get this information. All your personal information will maintain secrecy.

Links to Other Websites

If you apply to a job through our Site, you might be directed to other websites operated by Third Party. This Privacy Statement does not extend to any of these websites. Genhouse will not be responsible for any personal information collected by these websites operated by Third Party. Therefore, for any cases that a Third Party collect or use your personal information, Genhouse will not be legally responsible. We advise you to contact those websites directly and get their policies on personal information collection, safety, sharing and disclosure.

Contact Information

If you have any questions about our Privacy Statement, please do not hesitate to contact us at [].

Effective and Last Updated: April 15th 2021